potential side effects of tirzepatide TrimRX Semaglutide vs Tirzepatide results

95% CI, 7.5-21.3

Mechanistically, Semaglutide and Liraglutide are both glucagon-like peptide-1 (GLP-1) receptor agonists, but Semaglutide has been modified to have a longer half-life and increased binding affinity, potentially contributing to its greater weight loss efficacy

Learn more about our Physicals Get the vaccinations you need when you need them

The current medications vary in mechanism and magnitude: Semaglutide (Ozempic) targets GLP-1 receptors - around 15% average weight loss Tirzepatide (Mounjaro) targets GLP-1 + GIP - around 20% weight loss, often better GI tolerance Retatrutide (Phase 3 Trials) targets three receptors around 24% weight loss in trials, with broader metabolic effects The real risk is muscle mass loss

I will be changing pharmacy which is a pity because Ive attended them for 20 years and some of the staff have been phenomenal